Zobrazeno 1 - 10
of 241
pro vyhledávání: '"JP Radich"'
Publikováno v:
Blood. 76:801-807
Point mutations of the N-ras proto-oncogenes have been previously detected in 20% to 60% of samples of acute myelogenous leukemia (AML), but the clinical significance of these mutations is presently unclear. We directly sequenced polymerase chain rea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b87bae3bf2412c5286acfd94f4acc07
https://doi.org/10.1182/blood.v76.4.801.bloodjournal764801
https://doi.org/10.1182/blood.v76.4.801.bloodjournal764801
Autor:
Qu X; Fred Hutchinson Cancer Center, Seattle, WA., Stevens E; Virginia Mason Franciscan Health, Seattle, WA., Fitzgibbon MP; Fred Hutchinson Cancer Center, Seattle, WA., Beppu L; Fred Hutchinson Cancer Center, Seattle, WA., Monahan TM; Fred Hutchinson Cancer Center, Seattle, WA., Yeung C; Fred Hutchinson Cancer Center, Seattle, WA; University of Washington, Seattle, WA., Stirewalt DL; Fred Hutchinson Cancer Center, Seattle, WA; University of Washington, Seattle, WA., Wu D; University of Washington, Seattle, WA., Radich JP; Fred Hutchinson Cancer Center, Seattle, WA; University of Washington, Seattle, WA., Deeg HJ; Fred Hutchinson Cancer Center, Seattle, WA; University of Washington, Seattle, WA., Fang M; Fred Hutchinson Cancer Center, Seattle, WA; University of Washington, Seattle, WA. Electronic address: mfang@fredhutch.org.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Dec 23. Date of Electronic Publication: 2024 Dec 23.
Autor:
Naru J; Translational Science and Therapeutics Division Fred Hutch Seattle Washington USA., Othus M; Translational Science and Therapeutics Division Fred Hutch Seattle Washington USA.; SWOG Statistics and Data Management Center Fred Hutch Seattle Washington USA., Lin C; Translational Science and Therapeutics Division Fred Hutch Seattle Washington USA., Biernacki MA; Translational Science and Therapeutics Division Fred Hutch Seattle Washington USA.; Departments of Oncology and Hematology University of Washington Seattle Washington USA., Bleakley M; Translational Science and Therapeutics Division Fred Hutch Seattle Washington USA.; Department of Pediatrics University of Washington Seattle Washington USA., Chauncey TR; Translational Science and Therapeutics Division Fred Hutch Seattle Washington USA.; Departments of Oncology and Hematology University of Washington Seattle Washington USA.; VA Puget Sound Health Care System Seattle Washington USA., Erba HP; Duke Cancer Institute Durham North Carolina USA., Fang M; Translational Science and Therapeutics Division Fred Hutch Seattle Washington USA.; Departments of Laboratory Medicine and Pathology University of Washington Seattle Washington USA., Fitzgibbon MP; Genomics and Bioinformatics Shared Resource Fred Hutch Seattle Washington USA., Gafken PR; Proteomics and Metabolomics Shared Resource Fred Hutch Seattle Washington USA., Ivey RG; Translational Science and Therapeutics Division Fred Hutch Seattle Washington USA., Kennedy JJ; Translational Science and Therapeutics Division Fred Hutch Seattle Washington USA., Lorentzen TD; Translational Science and Therapeutics Division Fred Hutch Seattle Washington USA., Meshinchi S; Translational Science and Therapeutics Division Fred Hutch Seattle Washington USA.; Department of Pediatrics University of Washington Seattle Washington USA., Moseley A; Translational Science and Therapeutics Division Fred Hutch Seattle Washington USA.; SWOG Statistics and Data Management Center Fred Hutch Seattle Washington USA., Pogosova-Agadjanyan EL; Translational Science and Therapeutics Division Fred Hutch Seattle Washington USA., Liu VM; Translational Science and Therapeutics Division Fred Hutch Seattle Washington USA.; Departments of Oncology and Hematology University of Washington Seattle Washington USA., Radich JP; Translational Science and Therapeutics Division Fred Hutch Seattle Washington USA.; Departments of Oncology and Hematology University of Washington Seattle Washington USA., Voytovich UJ; Translational Science and Therapeutics Division Fred Hutch Seattle Washington USA., Wang P; Department of Genetics and Genomics Icahn School of Medicine at Mount Sinai New York New York USA., Whiteaker JR; Translational Science and Therapeutics Division Fred Hutch Seattle Washington USA., Willman CL; Department of Laboratory Medicine and Pathology Mayo Clinic Comprehensive Cancer Center Rochester Minnesota USA., Wu F; Genomics and Bioinformatics Shared Resource Fred Hutch Seattle Washington USA., Paulovich AG; Translational Science and Therapeutics Division Fred Hutch Seattle Washington USA.; Departments of Oncology and Hematology University of Washington Seattle Washington USA., Stirewalt DL; Translational Science and Therapeutics Division Fred Hutch Seattle Washington USA.; Departments of Oncology and Hematology University of Washington Seattle Washington USA.
Publikováno v:
EJHaem [EJHaem] 2024 Oct 25; Vol. 5 (6), pp. 1243-1251. Date of Electronic Publication: 2024 Oct 25 (Print Publication: 2024).
Autor:
Oshima MU; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Division of Hematology & Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA., Higgins J; TwinStrand Biosciences, Seattle, WA 98121, USA., Jenkins I; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Randolph T; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Smith T; TwinStrand Biosciences, Seattle, WA 98121, USA., Valentine C 3rd; TwinStrand Biosciences, Seattle, WA 98121, USA., Salk J; Division of Hematology & Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA.; TwinStrand Biosciences, Seattle, WA 98121, USA., Yeung C; Department of Pathology, University of Washington School of Medicine, Seattle, WA 98195, USA.; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Beppu L; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Campbell J; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Carpenter PA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA 98195, USA., Lee SJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Division of Hematology & Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA., Flowers ME; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Division of Hematology & Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA., Radich JP; Division of Hematology & Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA.; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Storb R; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Division of Hematology & Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA.
Publikováno v:
Science translational medicine [Sci Transl Med] 2024 Oct 23; Vol. 16 (770), pp. eado5108. Date of Electronic Publication: 2024 Oct 23.
Autor:
Sala-Torra O; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Beppu L; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Wu Q; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Welch E; Tasso, Inc., Seattle, WA, USA., Berthier E; Tasso, Inc., Seattle, WA, USA., Radich JP; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA, USA., Oehler VG; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. voehler@fredhutch.org.; Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA, USA. voehler@fredhutch.org.
Publikováno v:
Leukemia [Leukemia] 2024 Aug; Vol. 38 (8), pp. 1822-1824. Date of Electronic Publication: 2024 Jun 15.
Autor:
Kockerols C; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Valk PJM; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Dulucq S; Laboratory of Hematology, Hôpital Haut Lévêque, University hospital of Bordeaux, Pessac, France., Nicolini FE; Department of Hematology, Centre Léon Bérard and CRCL, Lyon, France., Mahon FX; Department of Hematology, Institut Bergonié, Bordeaux, France.; INSERM Unit BRIC 1312, Bordeaux University, Bordeaux, France., Atallah E; Department of Internal Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Mauro MJ; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Radich JP; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Bernardi S; Department of Clinical and Experimental Sciences, Hematology 2 and Bone Marrow Transplant Center, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy., Russo D; Department of Clinical and Experimental Sciences, Hematology 2 and Bone Marrow Transplant Center, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy., Farina M; Department of Clinical and Experimental Sciences, Hematology 2 and Bone Marrow Transplant Center, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy., Mori S; Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy., Gambacorti-Passerini C; Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy.; Department of Hematology, S. Gerardo Hospital, Monza, Italy., Civettini I; Department of Medicine and Surgery, University of Milano Bicocca, Monza, Italy.; Department of Hematology, S. Gerardo Hospital, Monza, Italy., Lu L; South Australia Health and Medical Research Institute, University of Adelaide Medical School and Precision Cancer Medicine Theme, Adelaide, Australia., Yeung D; South Australia Health and Medical Research Institute, University of Adelaide Medical School and Precision Cancer Medicine Theme, Adelaide, Australia., Branford S; Department of Genetics and Molecular Pathology, Centre for Cancer Biology, SA Pathology, Adelaide, Australia.; Clinical and Health Sciences, University of South Australia, Adelaide, Australia.; School of Medicine, The University of Adelaide, Adelaide, Australia., Colafigli G; Department of Translational and Precision Medicine, Az. Policlinico Umberto I-Sapienza University, Rome, Italy., Breccia M; Department of Translational and Precision Medicine, Az. Policlinico Umberto I-Sapienza University, Rome, Italy., Hogenbirk P; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., van Rosmalen J; Department of Biostatistics, Erasmus University Medical Center, Rotterdam, The Netherlands.; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands., Cornelissen JJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Westerweel PE; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
Publikováno v:
American journal of hematology [Am J Hematol] 2024 Aug; Vol. 99 (8), pp. 1632-1635. Date of Electronic Publication: 2024 May 20.
Autor:
Dillon LW; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Higgins J; TwinStrand Biosciences, Seattle, WA., Nasif H; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA., Othus M; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA., Beppu L; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Smith TH; TwinStrand Biosciences, Seattle, WA., Schmidt E; TwinStrand Biosciences, Seattle, WA., Valentine Iii CC; TwinStrand Biosciences, Seattle, WA., Salk JJ; TwinStrand Biosciences, Seattle, WA., Wood BL; Dept. of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA., Erba HP; Duke University School of Medicine, Durham, NC., Radich JP; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA., Hourigan CS; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD; Myeloid Malignancies Program, National Institutes of Health, Bethesda, MD. hourigan@nih.gov.
Publikováno v:
Haematologica [Haematologica] 2024 Feb 01; Vol. 109 (2), pp. 401-410. Date of Electronic Publication: 2024 Feb 01.
Autor:
Garcia-Manero G; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA., Podoltsev NA; Yale School of Medicine, New Haven, CT, USA. nikolai.podoltsev@yale.edu., Othus M; SWOG Statistics and Data Management Center, Seattle, WA, USA., Pagel JM; Swedish Cancer Institute, Seattle, WA, USA., Radich JP; Fred Hutchinson Cancer Center, Seattle, WA, USA., Fang M; Fred Hutchinson Cancer Center, Seattle, WA, USA., Rizzieri DA; Duke University Medical Center, Durham, NC, USA., Marcucci G; Ohio State University (Alliance), Columbus, OH, USA.; City of Hope, Duarte, CA, USA., Strickland SA; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.; Sarah Cannon, Nashville, TN, USA., Litzow MR; Mayo Clinic, Rochester, MN, USA., Savoie ML; Tom Baker Cancer Centre, Calgary, AB, Canada., Medeiros BC; Stanford University, Stanford, CA, USA., Sekeres MA; Cleveland Clinic, Cleveland, OH, USA.; University of Miami, Maiami, FL, USA., Lin TL; University of Kansas Medical Center, Kansas City, KS, USA., Uy GL; Washington University School of Medicine, St. Louis, USA., Powell BL; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA., Kolitz JE; North Shore University Hospital, Manhasset, NY, USA., Larson RA; University of Chicago, Chicago, IL, USA., Stone RM; Dana Farber Cancer Institute, Boston, MA, USA., Claxton D; Pennsylvania State Milton S Hershey Medical Center, Hummelstown, USA., Essell J; Jewish Hospital, Cincinnati, OH, USA., Luger SM; University of Pennsylvania Abramson Cancer Center, Philadelphia, PA, USA., Mohan SR; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.; Sarah Cannon, Nashville, TN, USA., Moseley A; SWOG Statistics and Data Management Center, Seattle, WA, USA., Appelbaum FR; Fred Hutchinson Cancer Center, Seattle, WA, USA., Erba HP; Duke University Cancer Center, Durham, NC, USA.
Publikováno v:
Leukemia [Leukemia] 2024 Jan; Vol. 38 (1), pp. 58-66. Date of Electronic Publication: 2023 Nov 07.
Autor:
Winn AN; Department of Health Systems, Outcomes and Policy, School of Pharmacy, University of Illinois at Chicago., Atallah E; Department of Medicine, Medical College of Wisconsin, Milwaukee., Cortes J; Georgia Cancer Center, Augusta University Medical Center, Augusta., Deininger MWN; Department of Medicine, Medical College of Wisconsin, Milwaukee., Kota V; Georgia Cancer Center, Augusta University Medical Center, Augusta., Larson RA; Department of Medicine and Comprehensive Cancer Center, University of Chicago, Chicago, Illinois., Moore JO; Duke University School of Medicine, Durham, North Carolina., Mauro MJ; Memorial Sloan Kettering Cancer Center, New York, New York., Oehler VG; Fred Hutchinson Cancer Research Center, Seattle, Washington., Pinilla-Ibarz J; H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida., Radich JP; Fred Hutchinson Cancer Research Center, Seattle, Washington., Shah NP; Department of Medicine, University of California at San Francisco., Thompson JE; Roswell Park Comprehensive Cancer Center, Buffalo, New York., Flynn KE; Department of Medicine, Medical College of Wisconsin, Milwaukee.
Publikováno v:
JAMA network open [JAMA Netw Open] 2023 Dec 01; Vol. 6 (12), pp. e2347950. Date of Electronic Publication: 2023 Dec 01.
Autor:
Cross NCP; Faculty of Medicine, University of Southampton, Southampton, UK. ncpc@soton.ac.uk., Ernst T; Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany., Branford S; Centre for Cancer Biology and SA Pathology, Adelaide, SA, Australia., Cayuela JM; Laboratory of Hematology, University Hospital Saint-Louis, AP-HP and EA3518, Université Paris Cité, Paris, France., Deininger M; Huntsman Cancer Center Salt Lake City, Salt Lake City, UT, USA., Fabarius A; III. Medizinische Klinik, Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany., Kim DDH; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada., Machova Polakova K; Institute of Hematology and Blood Transfusion, Prague, Czech Republic., Radich JP; Fred Hutchinson Cancer Center, Seattle, WA, USA., Hehlmann R; III. Medizinische Klinik, Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany.; ELN Foundation, Weinheim, Germany., Hochhaus A; Klinik für Innere Medizin II, Universitätsklinikum Jena, Jena, Germany., Apperley JF; Centre for Haematology, Imperial College London, London, UK.; Department of Clinical Haematology, Imperial College Healthcare NHS Trust, London, UK., Soverini S; Department of Medical and Surgical Sciences, Institute of Hematology 'Lorenzo e Ariosto Seràgnoli', University of Bologna, Bologna, Italy.
Publikováno v:
Leukemia [Leukemia] 2023 Nov; Vol. 37 (11), pp. 2150-2167. Date of Electronic Publication: 2023 Oct 04.